Publications

cAMP-Signalling Regulates Gametocyte-Infected Erythrocyte Deformability Required for Malaria Parasite Transmission.

Ramdani, G; Naissant, B; Thompson, E; Breil, F; Lorthiois, A; Dupuy, F; Cummings, R; Duffier, Y; Corbett, Y; Mercereau-Puijalon, O; Vernick, K; Taramelli, D; BAKER, DA; Langsley, G; Lavazec, C;

2015

PLoS pathogens, (2015).11 5 10.1371/journal.ppat.1004815.

Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination.

Noviyanti, R; Coutrier, F; Utami, RA S; Trimarsanto, H; Tirta, YK; Trianty, L; Kusuma, A; Sutanto, I; Kosasih, A; Kusriastuti, R; Hawley, WA; Laihad, F; Lobo, N; Marfurt, J; CLARK, TG; Price, RN; Auburn, S;

2015

PLoS neglected tropical diseases, (2015).9 5 10.1371/journal.pntd.0003739.

Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries.

PALAFOX, B; PATOUILLARD, E; TOUGHER, S; GOODMAN, C; HANSON, K; KLEINSCHMIDT, I; TORRES RUEDA, S; Kiefer, S; O'Connell, K; Zinsou, C; Phok, S; Akulayi, L; Arogundade, E; Buyungo, P; Mpasela, F; Poyer, S; Chavasse, D;

2015

Health policy and planning, (2015).31 2 10.1093/heapol/czv031.

Imputation-based population genetics analysis of Plasmodium falciparum malaria parasites.

Samad, H; COLL, F; PRESTON, MD; Ocholla, H; Fairhurst, RM; CLARK, TG;

2015

PLoS genetics, (2015).11 4 10.1371/journal.pgen.1005131.

Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.

Oladipo, OO; Wellington, OA; SUTHERLAND, CJ;

2015

Diagnostic pathology, (2015).10 1 10.1186/s13000-015-0276-2.

Serological evidence of vector and parasite exposure in Southern Ghana: the dynamics of malaria transmission intensity.

Badu, K; Gyan, B; Appawu, M; Mensah, D; Dodoo, D; Yan, G; DRAKELEY, C; Zhou, G; Owusu-Dabo, E; Koram, KA;

2015

Parasites & vectors, (2015).8 1 10.1186/s13071-015-0861-y.

Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.

Sicuri, E; FERNANDES, S; Macete, E; González, R; Mombo-Ngoma, G; Massougbodgi, A; Abdulla, S; Kuwawenaruwa, A; Katana, A; Desai, M; Cot, M; Ramharter, M; Kremsner, P; Slustker, L; Aponte, J; HANSON, K; Menéndez, C;

2015

PloS one, (2015).10 4 10.1371/journal.pone.0125072.

Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013.

Morris, U; Xu, W; Msellem, MI; Schwartz, A; Abass, A; Shakely, D; COOK, J; Bhattarai, A; Petzold, M; Greenhouse, B; Ali, AS; Björkman, A; Fröberg, G; Mårtensson, A;

2015

Infection, genetics and evolution, (2015).33, 10.1016/j.meegid.2015.04.018.

Keeping ahead of the resistance curve: product bundling to conserve artemisinin-based combination therapy.

DAR, OA; Rokadiya, S; HEYMANN, DL;

2015

The Lancet Global health, (2015).3 6 10.1016/S2214-109X(15)70018-5.

Implementation of the integrated management of childhood illness with parasitological diagnosis of malaria in rural Ghana: health worker perceptions.

Febir, LG; BAIDEN, FE; Agula, J; Delimini, RK; Akpalu, B; Tivura, M; Amanfo, N; CHANDRAMOHAN, D; OWUSU-AGYEI, S; WEBSTER, J;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0699-y.